Takahashi T - Search Results

1

Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction.

Endoh H, Tomida S, Yatabe Y, Konishi H, Osada H, Tajima K, Kuwano H, Takahashi T, Mitsudomi T. Endoh H, et al. Among authors: takahashi t. J Clin Oncol. 2004 Mar 1;22(5):811-9. doi: 10.1200/JCO.2004.04.109. J Clin Oncol. 2004. PMID: 14990636

2

Identification of frequent G(2) checkpoint impairment and a homozygous deletion of 14-3-3epsilon at 17p13.3 in small cell lung cancers.

Konishi H, Nakagawa T, Harano T, Mizuno K, Saito H, Masuda A, Matsuda H, Osada H, Takahashi T. Konishi H, et al. Among authors: takahashi t. Cancer Res. 2002 Jan 1;62(1):271-6. Cancer Res. 2002. PMID: 11782387

3

Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers.

Mizuno K, Osada H, Konishi H, Tatematsu Y, Yatabe Y, Mitsudomi T, Fujii Y, Takahashi T. Mizuno K, et al. Among authors: takahashi t. Oncogene. 2002 Apr 4;21(15):2328-33. doi: 10.1038/sj.onc.1205402. Oncogene. 2002. PMID: 11948416

4

Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers.

Osada H, Tatematsu Y, Yatabe Y, Nakagawa T, Konishi H, Harano T, Tezel E, Takada M, Takahashi T. Osada H, et al. Among authors: takahashi t. Oncogene. 2002 Apr 4;21(15):2418-24. doi: 10.1038/sj.onc.1205303. Oncogene. 2002. PMID: 11948426

5

Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo.

Koshikawa K, Osada H, Kozaki K, Konishi H, Masuda A, Tatematsu Y, Mitsudomi T, Nakao A, Takahashi T. Koshikawa K, et al. Among authors: takahashi t. Oncogene. 2002 Apr 25;21(18):2822-8. doi: 10.1038/sj.onc.1205405. Oncogene. 2002. PMID: 11973641

6

TTF-1 expression in pulmonary adenocarcinomas.

Yatabe Y, Mitsudomi T, Takahashi T. Yatabe Y, et al. Among authors: takahashi t. Am J Surg Pathol. 2002 Jun;26(6):767-73. doi: 10.1097/00000478-200206000-00010. Am J Surg Pathol. 2002. PMID: 12023581

7

Increased expression of COX-2 in the development of human lung cancers.

Takahashi T, Kozaki K, Yatabe Y, Achiwa H, Hida T. Takahashi T, et al. J Environ Pathol Toxicol Oncol. 2002;21(2):177-81. J Environ Pathol Toxicol Oncol. 2002. PMID: 12086404

8

Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.

Osada H, Takahashi T. Osada H, et al. Among authors: takahashi t. Oncogene. 2002 Oct 21;21(48):7421-34. doi: 10.1038/sj.onc.1205802. Oncogene. 2002. PMID: 12379883 Review.

9

Decreased expression of 14-3-3sigma in neuroendocrine tumors is independent of origin and malignant potential.

Yatabe Y, Osada H, Tatematsu Y, Mitsudomi T, Takahashi T. Yatabe Y, et al. Among authors: takahashi t. Oncogene. 2002 Nov 28;21(54):8310-9. doi: 10.1038/sj.onc.1206014. Oncogene. 2002. PMID: 12447694

10

Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer.

Konishi H, Sugiyama M, Mizuno K, Saito H, Yatabe Y, Takahashi T, Osada H, Takahashi T. Konishi H, et al. Among authors: takahashi t. Oncogene. 2003 Mar 27;22(12):1892-905. doi: 10.1038/sj.onc.1206304. Oncogene. 2003. PMID: 12660825

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,961 results

Search Page

Filters